1. Home
  2. DCX vs INDP Comparison

DCX vs INDP Comparison

Compare DCX & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Digital Currency X Technology Inc. Class A Ordinary Shares

DCX

Digital Currency X Technology Inc. Class A Ordinary Shares

N/A

Current Price

$2.21

Market Cap

4.5M

Sector

Industrials

ML Signal

N/A

Logo Indaptus Therapeutics Inc.

INDP

Indaptus Therapeutics Inc.

HOLD

Current Price

$1.24

Market Cap

5.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCX
INDP
Founded
2009
2000
Country
China
United States
Employees
1389
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5M
5.2M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
DCX
INDP
Price
$2.21
$1.24
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
121.3K
32.8K
Earning Date
05-14-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.34
$0.27
52 Week High
$5.68
$13.24

Technical Indicators

Market Signals
Indicator
DCX
INDP
Relative Strength Index (RSI) 52.10 25.62
Support Level $2.02 N/A
Resistance Level $2.22 $2.08
Average True Range (ATR) 0.19 0.23
MACD -0.02 -0.13
Stochastic Oscillator 40.45 1.89

Price Performance

Historical Comparison
DCX
INDP

About DCX Digital Currency X Technology Inc. Class A Ordinary Shares

Digital Currency X Technology Inc, formerly Chijet Motor Company Inc is engaged in the development, manufacture, sales, and service of new energy vehicles (NEV), hybrid vehicles and traditional fuel vehicles in China. New energy vehicles refer to plug-in electric vehicles, including battery electric vehicles, plug-in hybrid (PHEV) electric vehicles, and fuel cell electric vehicles. Its passenger vehicles include small cars, sedans, and sports utility vehicles, or SUVs, and commercial vehicles include light trucks and vans. The company generates all of its revenue from PRC.

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a clinical biotechnology company that has developed a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. Its approach is based on the hypothesis that efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals that can be administered safely intravenously. Its patented technology is composed of single strains of attenuated and killed, non-pathogenic, Gram-negative bacteria, designed to have reduced i.v. toxicity, but largely uncompromised ability to prime or activate many of the cellular components of innate and adaptive immunity. Its candidate, Decoy20 is for patients with solid tumors.

Share on Social Networks: